Why New Journals? The Growth of the EJNMMI Family Ignasi CarrióArturo Chiti Editorial 12 August 2015 Pages: 1625 - 1626
Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping? Sergi Vidal-SicartFijs W. B. van LeeuwenRenato A. Valdés Olmos Editorial Commentary 22 July 2015 Pages: 1627 - 1630
Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-99mTc-nanocolloid hybrid tracer versus 99mTc-nanocolloid Ingo StoffelsJulia LeyhJoachim Klode Original Article 31 May 2015 Pages: 1631 - 1638
First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery Nynke S. van den BergHervé SimonFijs W. B. van Leeuwen Original Article 25 June 2015 Pages: 1639 - 1647
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment? Laura EvangelistaAnna Rita CervinoPierfranco Conte Original Article 31 May 2015 Pages: 1648 - 1655
Diagnostic accuracy of 18F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T Heinrich F. MagometschniggPascal A. BaltzerKatja Pinker Original Article 30 June 2015 Pages: 1656 - 1665
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtype Brittany Z. DashevskyDebra A. GoldmanGary A. Ulaner Original Article 14 May 2015 Pages: 1666 - 1673
Positron emission tomography of tumour [18F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy Michel van KruchtenAndor W. J. M. GlaudemansGeke A. P. Hospers Original Article Open access 20 June 2015 Pages: 1674 - 1681
Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer? David GroheuxMohamed MajdoubDimitris Visvikis Original Article 04 July 2015 Pages: 1682 - 1691
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer? Christina BluemelAndreas CramerKen Herrmann Original Article 09 July 2015 Pages: 1692 - 1699
PET-based compartmental modeling of 124I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer Pat ZanzonicoJorge A. CarrasquilloSteven M. Larson Original Article 21 July 2015 Pages: 1700 - 1706
PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates James C. KnightCaitríona ToppingBart Cornelissen Original Article 02 June 2015 Pages: 1707 - 1717
Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology C. ChiesaM. MiraV. Mazzaferro Original Article 27 June 2015 Pages: 1718 - 1738
DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy Uta EberleinCarina NowakMichael Lassmann Original Article Open access 06 June 2015 Pages: 1739 - 1749
EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma Christina BluemelKen HerrmannDomenico Rubello Guidelines 25 July 2015 Pages: 1750 - 1766
18F-NaF PET/CT: EANM procedure guidelines for bone imaging M. BeheshtiF. M. MottaghyW. Langsteger Guidelines 23 July 2015 Pages: 1767 - 1777
Assessment of amyloid deposits by 18F-florbetapir positron emission tomography Fernando Martínez-ValleMercedes GironellaCarles Lorenzo-Bosquet Image of the Month 17 June 2015 Pages: 1778 - 1779
Erratum to: First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery Nynke S. van den BergHervé SimonFijs W. B. van Leeuwen Erratum 11 July 2015 Pages: 1780 - 1780